Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 236 | 247 | 208 | 162 | 189 |
| Cost of Goods | N/A | N/A | N/A | N/A | 7 |
| Gross Profit | 236 | 247 | 208 | 162 | 182 |
| Operating Expenses | 869 | 950 | 1,536 | 846 | 885 |
| Operating Income | -633 | -703 | -1,328 | -684 | -696 |
| Interest Expense | 147 | 137 | 122 | 97 | 96 |
| Other Income | -689 | -11,667 | 591 | -294 | 635 |
| Pre-tax Income | -1,469 | -12,507 | -859 | -1,075 | -157 |
| Net Income Continuous | -1,469 | -12,507 | -859 | -1,075 | -157 |
| Net Income | $-1,469 | $-12,507 | $-859 | $-1,075 | $-157 |
| EPS Basic Total Ops | -103.75 | -631.50 | -76.50 | -91.50 | -44.25 |
| EPS Basic Continuous Ops | -69.00 | -596.91 | -41.50 | -57.31 | -7.72 |
| EPS Diluted Total Ops | -103.75 | -631.50 | -76.50 | -79.75 | -44.25 |
| EPS Diluted Continuous Ops | -69.00 | -596.91 | -41.50 | -55.28 | -7.72 |
| EBITDA(a) | $527 | $-703 | $-1,328 | $-683 | $-695 |